KF008-CITE-seq
Assay Information
Assay Name: KF008-CITE-seq
Study: EXP2
Investigation: Katia - COVID vaccinated SLE individuals
Assay Type: CITE-seq
Sequencing Platform: Illumina NovaSeq 6000
Pipeline Version: Not specified
Run Date: 2024-05-28
Samples (5)
Quality Status:
Track quality control results for each sample in this assay.
Pending = awaiting review,
Passed = meets QC criteria,
Failed = below QC thresholds,
Flagged = needs attention.
Click the dropdown to update status.
| Sample Name | Position | Barcode | Quality Status | Cell Type | Condition | Actions |
|---|---|---|---|---|---|---|
| KF008-HTC1 | Click to set |
SI-TT-B8
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy | ||
| KF008-HTC2 | Click to set |
SI-TT-B8
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy | ||
| KF008-HTC3 | Click to set |
SI-TT-B8
|
PE enriched SARS-CoV-2 Spike+ B cells | Healthy | ||
| KF008-HTC4 | Click to set |
SI-TT-B8
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE | ||
| KF008-HTC5 | Click to set |
SI-TT-B8
|
PE enriched SARS-CoV-2 Spike+ B cells | SLE |
Assay Timeline
Created:
2025-09-03 14:21 UTC
2025-09-03 14:21 UTC
Run Date:
2024-05-28
2024-05-28
Last Updated:
2025-11-20 16:55 UTC
2025-11-20 16:55 UTC
Assay Statistics
5
Total Samples
5 Pending